Bladder Cancer

Bladder cancer disproportionately affects older individuals, with diagnosis occurring at a median age of 73 years.

As a nurse, Brianne “Bree” Duncan, RN, BSN, has always had the goal to help and make a difference in her patients’ lives.

Researchers at New York University, Weill Cornell Medicine and New York Genome Center have developed and tested a two-step approach that uses whole-exome sequencing to find genes and pathways that predict response to immunotherapy.

Patients who received treatment for high-grade nonmuscle-invasive bladder cancer had similar outcomes irrespective of European Association of Urology risk status, results of a retrospective study showed.

The FDA granted fast track designation to several oncology and hematology therapies.

Men appeared to have a higher risk for cancer than women at most shared anatomic sites, according to study results published in Cancer.

CHICAGO — Patients with bone metastases due to urothelial carcinoma had worse outcomes than those without bone metastasis, regardless of treatment or PD-L1 expression, according to a poster presentation at ASCO Annual Meeting.

Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out of the hospital among patients with nonmetastatic bladder cancer.

Donna Hansel, MD, PhD, has been named division head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.

Efforts to limit overuse of surveillance testing and treatment for low-risk nonmuscle-invasive bladder cancer are needed to alleviate increasing costs of care, results of a population-based cohort study suggested.